TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 68 filers reported holding TRINITY BIOTECH PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 300 | +100.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | -94.6% | 150 | -95.3% | 0.00% | -100.0% |
| Q4 2015 | $37,000 | -14.0% | 3,202 | -11.8% | 0.00% | 0.0% |
| Q3 2015 | $43,000 | +290.9% | 3,632 | +500.3% | 0.00% | – |
| Q2 2015 | $11,000 | -8.3% | 605 | -5.6% | 0.00% | – |
| Q1 2015 | $12,000 | -14.3% | 641 | -20.4% | 0.00% | – |
| Q4 2014 | $14,000 | -84.1% | 805 | -83.2% | 0.00% | -100.0% |
| Q3 2014 | $88,000 | -22.1% | 4,805 | -1.7% | 0.00% | -33.3% |
| Q2 2014 | $113,000 | -15.0% | 4,890 | -11.2% | 0.00% | -25.0% |
| Q1 2014 | $133,000 | -4.3% | 5,504 | -0.5% | 0.00% | 0.0% |
| Q4 2013 | $139,000 | +18.8% | 5,531 | +3.3% | 0.00% | 0.0% |
| Q3 2013 | $117,000 | +41.0% | 5,354 | +9.2% | 0.00% | +33.3% |
| Q2 2013 | $83,000 | – | 4,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |